ZNF3
gene geneOn this page
Also known as A8-51KOX25PP838FLJ20216HF.12Zfp113
Summary
ZNF3 (zinc finger protein 3, HGNC:13089) is a protein-coding gene on chromosome 7q22.1, encoding Zinc finger protein 3 (P17036). Involved in cell differentiation and/or proliferation.
Enables identical protein binding activity. Predicted to be involved in regulation of transcription by RNA polymerase II. Predicted to be active in nucleus.
Source: NCBI Gene 7551 — RefSeq curated summary.
At a glance
- Gene–disease (curated): multiple congenital anomalies/dysmorphic syndrome (Limited, GenCC)
- GWAS associations: 3
- Clinical variants (ClinVar): 102 total
- MANE Select transcript:
NM_032924
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:13089 |
| Approved symbol | ZNF3 |
| Name | zinc finger protein 3 |
| Location | 7q22.1 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | A8-51, KOX25, PP838, FLJ20216, HF.12, Zfp113 |
| Ensembl gene | ENSG00000166526 |
| Ensembl biotype | protein_coding |
| OMIM | 194510 |
| Entrez | 7551 |
Gene structure
Transcript identifiers
Ensembl transcripts: 34 — 29 protein_coding, 5 retained_intron
ENST00000292393, ENST00000299667, ENST00000412947, ENST00000413658, ENST00000415068, ENST00000424697, ENST00000428683, ENST00000441298, ENST00000449785, ENST00000460331, ENST00000466121, ENST00000479192, ENST00000485892, ENST00000487620, ENST00000875768, ENST00000875769, ENST00000875770, ENST00000875771, ENST00000875772, ENST00000875773, ENST00000875774, ENST00000875775, ENST00000875776, ENST00000929076, ENST00000929077, ENST00000929078, ENST00000929079, ENST00000929080, ENST00000929081, ENST00000929082, ENST00000929083, ENST00000951836, ENST00000951837, ENST00000951838
RefSeq mRNA: 22 — MANE Select: NM_032924
NM_001278284, NM_001278287, NM_001278290, NM_001278291, NM_001278292, NM_001318135, NM_001318136, NM_001318137, NM_001362775, NM_001362776, NM_001362777, NM_001371210, NM_001371211, NM_001371212, NM_001371213, NM_001371214, NM_001371215, NM_001371216, NM_001371217, NM_001371218, NM_017715, NM_032924
CCDS: CCDS43618, CCDS43619, CCDS94152
Canonical transcript exons
ENST00000299667 — 6 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001103872 | 100079536 | 100079656 |
| ENSE00001133692 | 100069973 | 100072212 |
| ENSE00001181413 | 100081635 | 100081723 |
| ENSE00001942113 | 100075135 | 100075261 |
| ENSE00003570230 | 100077303 | 100077433 |
| ENSE00003571595 | 100075542 | 100075630 |
Expression profiles
Bgee: expression breadth ubiquitous, 264 present calls, max score 92.05.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 15.8937 / max 211.4608, expressed in 1786 samples.
FANTOM5 promoters (5 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 85136 | 14.6203 | 1780 |
| 85138 | 0.3856 | 139 |
| 85139 | 0.3230 | 121 |
| 85137 | 0.3053 | 132 |
| 85135 | 0.2594 | 87 |
Top tissues by expression
296 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| right uterine tube | UBERON:0001302 | 92.05 | gold quality |
| ganglionic eminence | UBERON:0004023 | 91.62 | gold quality |
| secondary oocyte | CL:0000655 | 91.29 | gold quality |
| cortical plate | UBERON:0005343 | 90.19 | gold quality |
| sural nerve | UBERON:0015488 | 89.29 | gold quality |
| embryo | UBERON:0000922 | 89.08 | gold quality |
| ventricular zone | UBERON:0003053 | 89.03 | gold quality |
| rectum | UBERON:0001052 | 88.92 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 88.91 | gold quality |
| small intestine Peyer’s patch | UBERON:0003454 | 88.38 | gold quality |
| transverse colon | UBERON:0001157 | 87.64 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 87.63 | gold quality |
| left ovary | UBERON:0002119 | 87.59 | gold quality |
| calcaneal tendon | UBERON:0003701 | 87.43 | gold quality |
| small intestine | UBERON:0002108 | 87.41 | gold quality |
| bronchial epithelial cell | CL:0002328 | 87.21 | gold quality |
| right lobe of liver | UBERON:0001114 | 87.21 | gold quality |
| body of uterus | UBERON:0009853 | 87.18 | gold quality |
| right ovary | UBERON:0002118 | 87.15 | gold quality |
| body of pancreas | UBERON:0001150 | 87.13 | gold quality |
| apex of heart | UBERON:0002098 | 87.05 | gold quality |
| left lobe of thyroid gland | UBERON:0001120 | 87.00 | gold quality |
| left uterine tube | UBERON:0001303 | 86.99 | gold quality |
| islet of Langerhans | UBERON:0000006 | 86.86 | gold quality |
| colonic epithelium | UBERON:0000397 | 86.83 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 86.81 | gold quality |
| metanephros cortex | UBERON:0010533 | 86.77 | gold quality |
| right lobe of thyroid gland | UBERON:0001119 | 86.69 | gold quality |
| endocervix | UBERON:0000458 | 86.63 | gold quality |
| nipple | UBERON:0002030 | 86.55 | gold quality |
Single-cell (SCXA)
Detected in 2 experiment(s), a significant marker in 2.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-GEOD-100618 | yes | 69.92 |
| E-ANND-3 | yes | 5.36 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
39 targeting ZNF3, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-4283 | 100.00 | 66.42 | 2097 |
| HSA-MIR-3646 | 100.00 | 73.56 | 5283 |
| HSA-MIR-454-3P | 99.91 | 74.01 | 1925 |
| HSA-MIR-301A-3P | 99.90 | 73.15 | 1839 |
| HSA-MIR-301B-3P | 99.90 | 73.19 | 1836 |
| HSA-MIR-130A-3P | 99.90 | 73.31 | 1861 |
| HSA-MIR-130B-3P | 99.90 | 73.27 | 1850 |
| HSA-MIR-3666 | 99.90 | 73.24 | 1833 |
| HSA-MIR-4295 | 99.90 | 73.11 | 1838 |
| HSA-MIR-6124 | 99.87 | 69.78 | 3551 |
| HSA-MIR-6739-5P | 99.80 | 67.87 | 2806 |
| HSA-MIR-4668-5P | 99.79 | 70.58 | 3782 |
| HSA-MIR-4679 | 99.76 | 69.19 | 1229 |
| HSA-MIR-148A-3P | 99.74 | 73.77 | 1700 |
| HSA-MIR-148B-3P | 99.74 | 73.75 | 1700 |
| HSA-MIR-152-3P | 99.74 | 73.75 | 1703 |
| HSA-MIR-6733-5P | 99.74 | 67.94 | 2759 |
| HSA-MIR-4306 | 99.72 | 70.50 | 3630 |
| HSA-MIR-518A-5P | 99.70 | 69.01 | 2209 |
| HSA-MIR-527 | 99.70 | 69.01 | 2209 |
| HSA-MIR-6757-3P | 99.63 | 66.88 | 1089 |
| HSA-MIR-3685 | 99.62 | 68.83 | 1621 |
| HSA-MIR-4437 | 99.52 | 65.29 | 1266 |
| HSA-MIR-3123 | 99.47 | 67.15 | 2693 |
| HSA-MIR-5695 | 99.41 | 67.48 | 1047 |
| HSA-MIR-302A-5P | 99.39 | 68.21 | 1913 |
| HSA-MIR-584-3P | 99.35 | 67.69 | 1082 |
| HSA-MIR-185-5P | 99.35 | 68.60 | 2497 |
| HSA-MIR-4644 | 99.35 | 69.12 | 2514 |
| HSA-MIR-544B | 99.18 | 67.41 | 1632 |
Literature-anchored findings (GeneRIF, showing 2)
- ZNF3 is a target gene of the BACH1 transcription factor according to ChIP-seq analysis in HEK 293 cells. (PMID:21555518)
- ZNF3 regulates proliferation, migration and invasion through MMP1 and TWIST in colorectal cancer. (PMID:36789689)
Cross-species orthologs
0 orthologs
Paralogs (176): ZNF195 (ENSG00000005801), ZNF112 (ENSG00000062370), ZNF275 (ENSG00000063587), ZNF37A (ENSG00000075407), ZNF510 (ENSG00000081386), ZNF506 (ENSG00000081665), ZNF268 (ENSG00000090612), MZF1 (ENSG00000099326), ZNF629 (ENSG00000102870), ZNF175 (ENSG00000105497), ZNF85 (ENSG00000105750), ZFP30 (ENSG00000120784), ZNF45 (ENSG00000124459), ZNF391 (ENSG00000124613), ZNF436 (ENSG00000125945), ZNF484 (ENSG00000127081), ZNF835 (ENSG00000127903), ZNF780B (ENSG00000128000), ZSCAN10 (ENSG00000130182), ZNF317 (ENSG00000130803), ZNF331 (ENSG00000130844), ZNF227 (ENSG00000131115), ZNF141 (ENSG00000131127), ZNF132 (ENSG00000131849), ZNF189 (ENSG00000136870), ZIM3 (ENSG00000141946), ZFP14 (ENSG00000142065), ZNF514 (ENSG00000144026), ZNF300 (ENSG00000145908), RBAK (ENSG00000146587), ZNF157 (ENSG00000147117), ZNF182 (ENSG00000147118), ZNF41 (ENSG00000147124), ZNF7 (ENSG00000147789), ZNF117 (ENSG00000152926), ZNF221 (ENSG00000159905), ZNF235 (ENSG00000159917), ZNF714 (ENSG00000160352), ZNF577 (ENSG00000161551), ZNF12 (ENSG00000164631)
Protein
Protein identifiers
Zinc finger protein 3 — P17036 (reviewed: P17036)
Alternative names: Zinc finger protein HF.12, Zinc finger protein HZF3.1, Zinc finger protein KOX25
All UniProt accessions (6): C9J5S8, C9JE35, C9JK31, P17036, F8WA60, Q86U76
UniProt curated annotations — full annotation on UniProt →
Function. Involved in cell differentiation and/or proliferation.
Subcellular location. Nucleus.
Similarity. Belongs to the krueppel C2H2-type zinc-finger protein family.
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| P17036-1 | 1 | yes |
| P17036-2 | 2 |
RefSeq proteins (22): NP_001265213, NP_001265216, NP_001265219, NP_001265220, NP_001265221, NP_001305064, NP_001305065, NP_001305066, NP_001349704, NP_001349705, NP_001349706, NP_001358139, NP_001358140, NP_001358141, NP_001358142, NP_001358143, NP_001358144, NP_001358145, NP_001358146, NP_001358147, NP_060185, NP_116313* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR001909 | KRAB | Domain |
| IPR013087 | Znf_C2H2_type | Domain |
| IPR036051 | KRAB_dom_sf | Homologous_superfamily |
| IPR036236 | Znf_C2H2_sf | Homologous_superfamily |
Pfam: PF00096, PF01352
UniProt features (23 total): zinc finger region 8, cross-link 6, sequence conflict 3, modified residue 2, chain 1, domain 1, splice variant 1, sequence variant 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-P17036-F1 | 66.67 | 0.30 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Post-translational modifications (8): 143, 419, 125, 151, 163, 173, 422, 431
Function
Pathways and Gene Ontology
Reactome pathways
1 pathways
| ID | Pathway |
|---|---|
| R-HSA-212436 | Generic Transcription Pathway |
MSigDB gene sets: 124 (showing top):
AFFAR_YY1_TARGETS_UP, TGCCTTA_MIR124A, TTTGCAC_MIR19A_MIR19B, CHEN_HOXA5_TARGETS_9HR_UP, CAGCTTT_MIR320, BOCHKIS_FOXA2_TARGETS, GOMF_SEQUENCE_SPECIFIC_DNA_BINDING, CACTGCC_MIR34A_MIR34C_MIR449, CHENG_RESPONSE_TO_NICKEL_ACETATE, BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_B, RAPA_EARLY_UP.V1_DN, E2F3_UP.V1_DN, SRC_UP.V1_DN, GOMF_TRANSCRIPTION_REGULATOR_ACTIVITY, ARID5B_TARGET_GENES
GO Biological Process (4): regulation of transcription by RNA polymerase II (GO:0006357), cell differentiation (GO:0030154), leukocyte activation (GO:0045321), regulation of DNA-templated transcription (GO:0006355)
GO Molecular Function (7): RNA polymerase II transcription regulatory region sequence-specific DNA binding (GO:0000977), DNA-binding transcription factor activity, RNA polymerase II-specific (GO:0000981), DNA binding (GO:0003677), zinc ion binding (GO:0008270), identical protein binding (GO:0042802), protein binding (GO:0005515), metal ion binding (GO:0046872)
GO Cellular Component (1): nucleus (GO:0005634)
Reactome top-level categories
Rollup of top-1 pathways:
| Category | Pathways |
|---|---|
| RNA Polymerase II Transcription | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| regulation of DNA-templated transcription | 1 |
| transcription by RNA polymerase II | 1 |
| cellular developmental process | 1 |
| cell activation | 1 |
| immune system process | 1 |
| DNA-templated transcription | 1 |
| regulation of gene expression | 1 |
| regulation of RNA biosynthetic process | 1 |
| transcription cis-regulatory region binding | 1 |
| chromatin | 1 |
| RNA polymerase II transcription regulatory region sequence-specific DNA binding | 1 |
| DNA-binding transcription factor activity | 1 |
| regulation of transcription by RNA polymerase II | 1 |
| nucleic acid binding | 1 |
| transition metal ion binding | 1 |
| protein binding | 1 |
| binding | 1 |
| cation binding | 1 |
| intracellular membrane-bounded organelle | 1 |
Protein interactions and networks
STRING
0 interactions, top by confidence (×1000):
IntAct
71 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| KBTBD7 | METTL15 | psi-mi:“MI:0914”(association) | 0.730 |
| ZNF3 | TRAF4 | psi-mi:“MI:0915”(physical association) | 0.720 |
| TRAF4 | ZNF3 | psi-mi:“MI:0915”(physical association) | 0.720 |
| ZNF3 | MTUS2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| SSX2IP | ZNF3 | psi-mi:“MI:0915”(physical association) | 0.560 |
| MTUS2 | ZNF3 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF3 | SSX2IP | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF3 | KRT27 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF3 | GOLGA2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF3 | SF3B4 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF3 | MCC | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF3 | NDEL1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF3 | LZTS1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| YJU2B | ZNF3 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF3 | ZNF3 | psi-mi:“MI:0407”(direct interaction) | 0.530 |
| ZNF3 | ZNF212 | psi-mi:“MI:0407”(direct interaction) | 0.530 |
| ZNF212 | ZNF3 | psi-mi:“MI:0407”(direct interaction) | 0.530 |
| ZNF3 | ACOT2 | psi-mi:“MI:0915”(physical association) | 0.400 |
| ZNF3 | ECE1 | psi-mi:“MI:0915”(physical association) | 0.370 |
| Prkci | LLGL2 | psi-mi:“MI:0914”(association) | 0.350 |
| Tsc1 | PYGB | psi-mi:“MI:0914”(association) | 0.350 |
| Nfya | NFYB | psi-mi:“MI:0914”(association) | 0.350 |
| ZNF3 | PTPRK | psi-mi:“MI:0914”(association) | 0.350 |
| CEP135 | MCRIP1 | psi-mi:“MI:0914”(association) | 0.350 |
| CEP135 | WWP2 | psi-mi:“MI:0914”(association) | 0.350 |
| ZNF3 | POLR1C | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (58): TRAF4 (Two-hybrid), MTUS2 (Two-hybrid), SSX2IP (Two-hybrid), ZNF3 (Affinity Capture-MS), ZNF3 (Affinity Capture-MS), ZNF3 (Affinity Capture-MS), SHCBP1 (Affinity Capture-MS), KBTBD7 (Affinity Capture-MS), PTPRK (Affinity Capture-MS), ZNF3 (Two-hybrid), ZNF3 (Two-hybrid), ZNF3 (Two-hybrid), ZNF3 (Two-hybrid), ZNF3 (Two-hybrid), ZNF3 (Two-hybrid)
ESM2 similar proteins: A0A087WUV0, A0JNB1, A2VDP4, B2RUI1, P0CG31, P10072, P17025, P17036, P17097, P18733, P51814, Q08ER8, Q09FC8, Q0VGE8, Q14590, Q15937, Q16600, Q2M3X9, Q4V8A8, Q5CZA5, Q5R8G9, Q5RBX0, Q5VIY5, Q68DI1, Q6J6I6, Q6NX49, Q6P1L6, Q6PG37, Q6ZMS4, Q6ZMW2, Q80YP6, Q86UD4, Q86Y25, Q8IZ26, Q8N184, Q8NB42, Q8NEK5, Q8TAF7, Q8TF47, Q8WXB4
Diamond homologs: A1YEP8, A1YEQ3, A1YEV9, A1YEW3, A1YFC1, A1YFW2, A1YFW6, A1YG26, A1YG48, A1YG60, A1YGJ4, A1YGK6, A2T6E3, A2T6V8, A2T6W2, A2T712, A2T736, A2T7D2, A2T7D7, A2T7F2, A2T7F4, A2T7L7, A2T812, A6QNZ0, B2KFW1, O14709, O14771, O14978, O15535, O43309, O60304, O95125, P10073, P17022, P17028, P17029, P17036, P17040, P28698, P49910
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
102 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 84 |
| Likely benign | 8 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
1142 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 7:100072209:CGAT:C | acceptor_gain | 1.0000 |
| 7:100072212:TC:T | acceptor_loss | 1.0000 |
| 7:100072213:C:CC | acceptor_gain | 1.0000 |
| 7:100072217:C:CT | acceptor_gain | 1.0000 |
| 7:100075129:CCTTA:C | donor_loss | 1.0000 |
| 7:100075130:CTTAC:C | donor_loss | 1.0000 |
| 7:100075131:TTACC:T | donor_loss | 1.0000 |
| 7:100075132:TA:T | donor_loss | 1.0000 |
| 7:100075133:A:AC | donor_gain | 1.0000 |
| 7:100075133:AC:A | donor_gain | 1.0000 |
| 7:100075133:ACCCA:A | donor_loss | 1.0000 |
| 7:100075134:C:CC | donor_gain | 1.0000 |
| 7:100075134:CC:C | donor_gain | 1.0000 |
| 7:100075150:T:A | donor_gain | 1.0000 |
| 7:100075536:GCTCA:G | donor_loss | 1.0000 |
| 7:100075537:CTCA:C | donor_loss | 1.0000 |
| 7:100075538:TCA:T | donor_loss | 1.0000 |
| 7:100075539:CA:C | donor_loss | 1.0000 |
| 7:100075541:C:A | donor_loss | 1.0000 |
| 7:100075627:AGAG:A | acceptor_gain | 1.0000 |
| 7:100075628:GAG:G | acceptor_gain | 1.0000 |
| 7:100075631:C:CC | acceptor_gain | 1.0000 |
| 7:100072219:C:CT | acceptor_gain | 0.9900 |
| 7:100072220:A:T | acceptor_gain | 0.9900 |
| 7:100075134:CCCA:C | donor_gain | 0.9900 |
| 7:100075167:A:AC | donor_gain | 0.9900 |
| 7:100075273:CGTG:C | acceptor_gain | 0.9900 |
| 7:100075540:A:AC | donor_gain | 0.9900 |
| 7:100075541:C:CC | donor_gain | 0.9900 |
| 7:100075626:AAGAG:A | acceptor_gain | 0.9900 |
AlphaMissense
2975 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 7:100071773:G:C | F237L | 0.998 |
| 7:100071773:G:T | F237L | 0.998 |
| 7:100071775:A:G | F237L | 0.998 |
| 7:100071437:G:C | F349L | 0.997 |
| 7:100071437:G:T | F349L | 0.997 |
| 7:100071439:A:G | F349L | 0.997 |
| 7:100071756:A:G | L243P | 0.997 |
| 7:100071269:G:C | F405L | 0.996 |
| 7:100071269:G:T | F405L | 0.996 |
| 7:100071271:A:G | F405L | 0.996 |
| 7:100071521:G:C | F321L | 0.996 |
| 7:100071521:G:T | F321L | 0.996 |
| 7:100071523:A:G | F321L | 0.996 |
| 7:100071605:G:C | F293L | 0.996 |
| 7:100071605:G:T | F293L | 0.996 |
| 7:100071607:A:G | F293L | 0.996 |
| 7:100071689:G:C | F265L | 0.996 |
| 7:100071689:G:T | F265L | 0.996 |
| 7:100071691:A:G | F265L | 0.996 |
| 7:100071746:A:C | H246Q | 0.996 |
| 7:100071746:A:T | H246Q | 0.996 |
| 7:100071353:A:C | F377L | 0.995 |
| 7:100071353:A:T | F377L | 0.995 |
| 7:100071355:A:G | F377L | 0.995 |
| 7:100071744:T:G | Q247P | 0.995 |
| 7:100071748:G:C | H246D | 0.995 |
| 7:100071410:G:C | H358Q | 0.994 |
| 7:100071410:G:T | H358Q | 0.994 |
| 7:100071672:A:G | L271P | 0.994 |
| 7:100071734:G:C | H250Q | 0.994 |
dbSNP variants (sampled 300 via entrez): RS1000146276 (7:100075885 T>A,C), RS1000312949 (7:100076085 G>A), RS1000449680 (7:100081729 A>G), RS1000490278 (7:100070426 C>T), RS1000604846 (7:100082539 T>A), RS1000757180 (7:100082264 G>A,T), RS1000782847 (7:100066184 T>C), RS1000842564 (7:100070667 C>G,T), RS1000869215 (7:100076124 C>G), RS1001053132 (7:100070238 G>A), RS1001256106 (7:100077717 C>T), RS1001301328 (7:100063652 T>C), RS1001307075 (7:100077424 T>C), RS1001399229 (7:100070074 A>G), RS1001679192 (7:100069011 GGAGA>G,GGA,GGAGAGA)
Disease associations
OMIM: gene MIM:194510 | disease phenotypes:
GenCC curated gene-disease
| Disease | Classification | Inheritance |
|---|---|---|
| multiple congenital anomalies/dysmorphic syndrome | Limited | Autosomal recessive |
Mondo (1): multiple congenital anomalies/dysmorphic syndrome (MONDO:0019042)
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
3 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST010002_259 | Refractive error | 3.000000e-16 |
| GCST010702_48 | Subcortical volume (MOSTest) | 6.000000e-10 |
| GCST010703_289 | Brain morphology (MOSTest) | 6.000000e-15 |
EFO canonical traits (1, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0004346 | neuroimaging measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
22 total (human), top 22 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| 3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamide | decreases expression | 1 |
| TAK-243 | increases sumoylation | 1 |
| sodium arsenite | increases expression, affects cotreatment, increases abundance | 1 |
| manganese chloride | affects cotreatment, increases abundance, increases expression | 1 |
| enzacamene | increases expression, affects response to substance | 1 |
| beta-methylcholine | affects expression | 1 |
| pentanal | decreases expression | 1 |
| CGP 52608 | affects binding, increases reaction | 1 |
| nickel acetate | affects expression | 1 |
| abrine | increases expression | 1 |
| Leflunomide | increases expression | 1 |
| Acetaminophen | decreases expression | 1 |
| Arsenic | affects cotreatment, increases abundance, increases expression | 1 |
| Benzo(a)pyrene | decreases methylation | 1 |
| Manganese | affects cotreatment, increases abundance, increases expression | 1 |
| Smoke | decreases expression | 1 |
| Tetrachlorodibenzodioxin | affects cotreatment, decreases expression | 1 |
| Dronabinol | decreases expression | 1 |
| Triiodothyronine | affects cotreatment, decreases expression | 1 |
| Valproic Acid | decreases expression | 1 |
| Antirheumatic Agents | increases expression | 1 |
| Copper Sulfate | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
- Associated diseases: multiple congenital anomalies/dysmorphic syndrome
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): multiple congenital anomalies/dysmorphic syndrome